A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer.

Jacob E ShabasonJerry ChenSmith ApisarnthanaraxNevena DamjanovBruce GiantonioArturo Loaiza-BonillaPeter J O'DwyerMark O'HaraKim A ReissUrsina TeitelbaumPaul WisselJeffrey A DrebinCharles VollmerMichael KochmanRosemarie MickNorge VergaraNirag JhalaAbigail DoucetteJohn N LukensJohn P PlastarasJames M MetzEdgar Ben-Josef

Published in: Cancer chemotherapy and pharmacology (2018)

The combination of fractionated radiation and weekly full dose nab-paclitaxel was safe and well-tolerated.

Keyphrases

locally advanced
advanced non small cell lung cancer
liver metastases
clinical trial
study protocol
radiation induced
phase iii
squamous cell carcinoma
open label
randomized controlled trial
small cell lung cancer
rectal cancer
epidermal growth factor receptor